Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample
- PMID: 16855128
- PMCID: PMC2713176
- DOI: 10.1177/0272989X06290496
Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample
Abstract
Background: Previous mapping algorithms estimating EQ-5D index scores from the SF-12 were based on preferences from a UK community sample. However, preferences based on the general US population are most appropriate for costeffectiveness analyses done from the societal perspective in the United States.
Objective: To provide a mapping algorithm for estimating EQ-5D index scores from the SF-12 based on a nationally representative sample and using preferences based on the general US population:
Methods: The Medical Expenditure Panel Survey (MEPS) 2002 and 2000 data were used as independent derivation and validation sets to estimate the relationship between SF-12 scores and EQ-5D index scores, controlling for sociodemographic characteristics and comorbidity burden. Prediction equations for end-users who only have access to SF-12 scores were derived and compared. The empirical performance of censored least absolute deviations (CLAD), Tobit, and ordinary least squares (OLS) analytic methods were compared by calculating the mean prediction error in the validation set.
Results: The fully specified CLAD model resulted in the lowest mean prediction error, followed by OLS and Tobit. The CLAD prediction equation based only on SF-12 scores performed better than the fully specified OLS and Tobit models.
Conclusion: The current research provides an algorithm for mapping EQ-5D index scores from the SF-12. This algorithm may provide analysts with an avenue to obtain appropriate preference-based health-related quality-of-life scores for use in cost-effectiveness analyses when only SF-12 data are available.
Figures
Comment in
-
As good as it gets but good enough for which applications?Med Decis Making. 2006 Jul-Aug;26(4):307-9. doi: 10.1177/0272989X06290975. Med Decis Making. 2006. PMID: 16855119 No abstract available.
-
National health preference data: a useful resource for health services research.Med Decis Making. 2006 Jul-Aug;26(4):310-2. doi: 10.1177/0272989X06291334. Med Decis Making. 2006. PMID: 16855120 No abstract available.
Similar articles
-
Preference-Based EQ-5D index scores for chronic conditions in the United States.Med Decis Making. 2006 Jul-Aug;26(4):410-20. doi: 10.1177/0272989X06290495. Med Decis Making. 2006. PMID: 16855129 Free PMC article.
-
Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.Value Health. 2012 Dec;15(8):1084-91. doi: 10.1016/j.jval.2012.07.007. Epub 2012 Nov 4. Value Health. 2012. PMID: 23244811 Clinical Trial.
-
Catalogue of EQ-5D scores for the United Kingdom.Med Decis Making. 2011 Nov-Dec;31(6):800-4. doi: 10.1177/0272989X11401031. Epub 2011 Mar 21. Med Decis Making. 2011. PMID: 21422468
-
Predicting EuroQoL EQ-5D preference scores from the SF-12 Health Survey in a nationally representative sample.Med Decis Making. 2004 Mar-Apr;24(2):160-9. doi: 10.1177/0272989X04264015. Med Decis Making. 2004. PMID: 15090102
-
The Short-Form 36 (SF-36) Health Survey and its use in pharmacoeconomic evaluation.Pharmacoeconomics. 1995 May;7(5):403-15. doi: 10.2165/00019053-199507050-00005. Pharmacoeconomics. 1995. PMID: 10155328 Review.
Cited by
-
Transperineal biopsy devices in people with suspected prostate cancer - a systematic review and economic evaluation.Health Technol Assess. 2024 Oct;28(60):1-213. doi: 10.3310/ZKTW8214. Health Technol Assess. 2024. PMID: 39364806 Free PMC article.
-
A systematic review of crosswalks for converting patient-reported outcome measure scores in hip, knee, and shoulder replacement surgery.Acta Orthop. 2024 Sep 13;95:512-523. doi: 10.2340/17453674.2024.41384. Acta Orthop. 2024. PMID: 39268815 Free PMC article.
-
Mapping the 12-item World Health Organization disability assessment schedule 2.0 (WHODAS 2.0) onto the assessment of quality of life (AQoL)-4D utilities.Qual Life Res. 2024 Feb;33(2):411-422. doi: 10.1007/s11136-023-03532-9. Epub 2023 Oct 31. Qual Life Res. 2024. PMID: 37906346 Free PMC article.
-
Mapping the Peds QLTM 4.0 onto CHU-9D: a cross-sectional study in functional dyspepsia population from China.Front Public Health. 2023 May 31;11:1166760. doi: 10.3389/fpubh.2023.1166760. eCollection 2023. Front Public Health. 2023. PMID: 37325313 Free PMC article.
-
Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048).J Clin Oncol. 2023 Jul 20;41(21):3724-3734. doi: 10.1200/JCO.23.00903. Epub 2023 Jun 4. J Clin Oncol. 2023. PMID: 37270691 Free PMC article. Clinical Trial.
References
-
- Gold MR, Siegel JE, Russell LB, Weinstein MC, editors. Cost-Effectiveness in Health and Medicine. Oxford Universit Press; New York: 1996.
-
- Drummond MF. Methods for the Economic Evaluation of Health Care Programmes. 2nd ed. Oxford University Press; Oxford, UK: 1997.
-
- Neumann PJ, Goldie SJ, Weinstein MC. Preference-based measures in economic evaluation in health care. Annu Rev Public Health. 2000;21:587–611. - PubMed
-
- Von Neumann J, Morgenstern O. Theory of Games and Economic Behavior. 2nd ed. Princeton University Press; Princeton, NJ: 1947.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources